Aeterna Zentaris Learns of Class Action Lawsuits Filed and Denies Allegations

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUÉBEC CITY, June 19, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") today announces that the Company has\n learned that two putative class action lawsuits have been filed against\n it alleging failures to disclose certain information under U.S. federal\n securities laws. The Company is in the process of reviewing the\n allegations, believes they are without merit and stands behind its\n continuous public disclosure record. Aeterna Zentaris believes that\n there is absolutely no basis for the lawsuits, and the Company intends\n to defend itself vigorously.\n\n\nAbout Aeterna Zentaris\n\n\nAeterna Zentaris is an oncology and endocrinology drug development\n company currently investigating treatments for various unmet medical\n needs. The Company's pipeline encompasses compounds at all stages of\n development, from drug discovery through to marketed products. For more\n information please visit www.aezsinc.com.\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected]  Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] \n","length":1468,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.